ADC Therapeutics (ADCT) EBIT Margin (QoQ) (2021 - 2026)
Powered by 
Analysis
ADC Therapeutics (ADCT) EBIT Margin (QoQ) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.86 Bn | 192.87 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.52 Bn | 176.34 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.47 Bn | 123.62 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.16 Bn | 55.98 Bn | 1.37 Bn |
| 6 | Moderna | 53.15 Bn | 48.02 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.20 Bn | 29.89 Bn | 992.69 Mn |
| 8 | Biogen | 31.65 Bn | 30.37 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.30 Bn | 29.30 Bn | 1.16 Mn |
| 10 | ADC Therapeutics | 180.59 Mn | -38.51 Mn | 17.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,096.00 |
| Sep 30, 2025 | 4,581.00 |
| Jun 30, 2025 | -11,076.00 |
| Sep 30, 2024 | -2,581.00 |
| Jun 30, 2024 | 1,938.00 |
| Sep 30, 2023 | -4,381.00 |
| Jun 30, 2023 | 6,593.00 |
| Sep 30, 2022 | 39,735.00 |
| Jun 30, 2022 | -31,462.00 |
| Sep 30, 2021 | 143,494.00 |